Prostate Cancer


Many patients at Seattle Cancer Care Alliance (SCCA) receive promising therapies by taking part in clinical trials. These research studies are done by physician-scientists from SCCA, Fred Hutchinson Cancer Research Center and UW Medicine. They test new treatments or new ways to use current treatments.

Every advance in cancer treatment in recent years has come out of clinical trials. We offer more active clinical trials than anywhere else, which means more treatment options for patients like you.

Clinical trials

For some people, taking part in a clinical study may be the best treatment choice. Access to clinical studies by researchers at SCCA and our founding organizations Fred Hutch and UW Medicine is one reason many patients come to SCCA. 

We’re active in finding new prostate cancer treatment options.

The Institute for Prostate Cancer Research (IPCR), a Fred Hutch–UW Medicine collaboration, brings together experts to devise therapies and new technologies in hopes of one day finding a cure. IPCR faculty received one of only 10 prostate cancer Specialized Program of Research Excellence (SPORE) grants nationwide from the National Cancer Institute to study prostate cancer progression.

SCCA also has researchers on the Stand Up 2 Cancer Prostate Cancer Dream Team.

Your SCCA team will talk with you about available studies that are appropriate for you and could give you access to promising new options.